Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6000 | 1477 | 31.3 | 56% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ALPHA1 ACID GLYCOPROTEIN | Author keyword | 61 | 40% | 8% | 118 |
| 2 | OROSOMUCOID | Author keyword | 44 | 49% | 4% | 65 |
| 3 | ALPHA 1 ACID GLYCOPROTEIN | Author keyword | 40 | 37% | 6% | 87 |
| 4 | RED EDGE EXCITATION SPECTRA | Author keyword | 12 | 86% | 0% | 6 |
| 5 | HUMAN SERUM ALPHA1 ACID GLYCOPROTEIN | Author keyword | 6 | 100% | 0% | 4 |
| 6 | HUMAN ALPHA 1 ACID GLYCOPROTEIN | Author keyword | 5 | 63% | 0% | 5 |
| 7 | ORM1 | Author keyword | 4 | 67% | 0% | 4 |
| 8 | TRP RESIDUES | Author keyword | 4 | 67% | 0% | 4 |
| 9 | LERISETRON | Author keyword | 4 | 75% | 0% | 3 |
| 10 | GLYCOIMMUNOL GRP | Address | 4 | 46% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HUMAN ALPHA 1 ACID GLYCOPROTEIN | 190 | 72% | 10% | 149 |
| 2 | TETRAANTENNARY GLYCANS | 49 | 94% | 1% | 17 |
| 3 | ALPHA1 ACID GLYCOPROTEIN | 45 | 27% | 10% | 146 |
| 4 | ALPHA 1 ACID GLYCOPROTEIN | 36 | 18% | 12% | 182 |
| 5 | OROSOMUCOID VARIANTS | 26 | 100% | 1% | 11 |
| 6 | ORM1 | 23 | 86% | 1% | 12 |
| 7 | MAIN GENETIC VARIANTS | 17 | 79% | 1% | 11 |
| 8 | INTERCURRENT INFECTION | 17 | 72% | 1% | 13 |
| 9 | CROSSED IMMUNO AFFINOELECTROPHORESIS | 12 | 86% | 0% | 6 |
| 10 | MICROHETEROGENEITY | 12 | 17% | 4% | 62 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| alpha(1)-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties | 2003 | 187 | 81 | 69% |
| Alpha-1-acid glycoprotein | 2000 | 417 | 117 | 69% |
| Human alpha-1-glycoprotein and its interactions with drugs | 2001 | 168 | 412 | 51% |
| The acute phase protein alpha 1-acid glycoprotein: A model for altered glycosylation during diseases | 2007 | 72 | 144 | 67% |
| DRUG-BINDING TO HUMAN ALPHA-1-ACID GLYCOPROTEIN IN HEALTH AND DISEASE | 1988 | 459 | 313 | 65% |
| Carbohydrate composition and immunomodulatory activity of different glycoforms of alpha(1)-acid glycoprotein | 1997 | 69 | 21 | 81% |
| Measurement and analysis of unbound drug concentrations | 1996 | 120 | 90 | 34% |
| N-GLYCOSYLATION OF SERUM-PROTEINS IN DISEASE AND ITS INVESTIGATION USING LECTINS | 1992 | 166 | 88 | 36% |
| Glycosylation of alpha(1)-acid glycoprotein (orosomucoid) in health and disease: Occurrence, regulation and possible functional implications | 1998 | 29 | 45 | 76% |
| Determination of Human Serum alpha(1)-Acid Glycoprotein and Albumin Binding of Various Marketed and Preclinical Kinase Inhibitors | 2009 | 19 | 77 | 44% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GLYCOIMMUNOL GRP | 4 | 46% | 0.4% | 6 |
| 2 | SERV HOSP PHARMACOL | 1 | 50% | 0.1% | 2 |
| 3 | PHARMKITA KU | 1 | 33% | 0.2% | 3 |
| 4 | EA 1595 | 1 | 40% | 0.1% | 2 |
| 5 | CHEM IMMUNOCHEM | 1 | 13% | 0.5% | 7 |
| 6 | AG PROTEINCHEM | 1 | 50% | 0.1% | 1 |
| 7 | ANIM PATHOL VET PUBL HLTH | 1 | 50% | 0.1% | 1 |
| 8 | DIPARTIMENTO CHIM TECNOL FARMACAO | 1 | 50% | 0.1% | 1 |
| 9 | NAT SCI MANAGEMENT | 1 | 50% | 0.1% | 1 |
| 10 | PATHOGEN AGENTS | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000121595 | HIGH PERFORMANCE AFFINITY CHROMATOGRAPHY//DRUG PROTEIN BINDING//HIGH PERFORMANCE FRONTAL ANALYSIS |
| 2 | 0.0000121097 | CIBENZOLINE//DISOPYRAMIDE//MONO N DEALKYLDISOPYRAMIDE |
| 3 | 0.0000099916 | DANSYLSARCOSINE//N B TRANSITION//FATTY ACID AVAILABILITY |
| 4 | 0.0000094283 | HAPTOGLOBIN//ACUTE PHASE PROTEIN//PIG MAP |
| 5 | 0.0000090935 | PROTEASE ANTIPROTEASE//RAT AND HUMAN ERYTHROCYTES//AFFECTED FACTOR |
| 6 | 0.0000077466 | MED HOSP PHARM YAHATANISHI KU//4 HYDROXYPROPRANOLOL//PROPRANOLOL METABOLISM |
| 7 | 0.0000057633 | SPATIAL VELOCITY ELECTROCARDIOGRAM//BISOPROLOL EFFICACY//INTRAVESICAL BCG INSTILLATION |
| 8 | 0.0000051343 | CARBAMAZEPINE 10 11 EPOXIDE//FREE PHENYTOIN//R 4PK |
| 9 | 0.0000050507 | 6 SULFANILAMIDOINDAZOLE//INULIN CLEARANCE//LIVER ANTIOXIDANT STATUS |
| 10 | 0.0000048416 | ECOL MED//ONCOPATHOLOGY//DIAGNOSTIC MEDICINE |